Henry E. Young

Background

About Henry E. Young

I started studying the regeneration of tissues during limb regeneration in the adult terrestrial salamander in 1975. My thoughts were, if terrestrial salamanders can do it, why can't humans. I have spent my entire career studying this phenomenon. The bottom line answer is HUMANS CAN REGENERATE THEIR OWN DAMAGED TISSUES USING ADULT-DERIVED STEM CELLS. My research has shown that humans contain a variety of very specific precursor cells: I have isolated and/or cloned from single cells: progenitor cells, specific germ layer lineage stem cells, pluripotent stem cells, and totipotent stem cells from adult mammals, including humans. These cells individually and/or in toto have the capabilities of forming all tissues of the body, the germ cells, and the cell types within the embryonic portion of the placenta. I have also discovered that the human body knows far more about the repair process that I would hope to discover in several lifetimes. Our results have shown that the best repair we have seen in our in vivo animal studies have used the most primitive of our isolated single cell-cloned stem cells, the totipotent stem cells. My ultimate goal is to see adult-derived (totipotent and pluripotent) stem cells, either autologous or allogeneic, used to treat the various afflictions that affect human life. I am interested in the application of adult-derived (totipotent and pluripotent) stem cells for the treatment of incurable diseases and incurable traumatic injuries. Specialties: Histochemistry, carbohydrate biochemistry, isolation of biologically active glycoproteins, proteoglycans, growth factors, hybridoma monoclonal antibodies, cell culture, CD-markers, single cell cloning, stem cell characterization, micro-array in vitro assays, flow cytometry, magnetic separation, animal surgery, wound healing, AD, ALS, CD, CIDP, COPD, IPF, MA, MD, MI, MS, OA, PD, SC, SLE, ST, TBI, TSCI, WH, nebulizations, neuropathies, intra-nasal infusions, IVs, scar inhibition, interested in incurable diseases and traumatic injuries with application of endogenous adult telomerase-positive stem cells, autologous and/or allogeneic.